4//SEC Filing
NYER MEDICAL GROUP INC 4
Accession 0001140361-08-003052
CIK 0000884647operating
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 7:17 PM ET
Size
13.0 KB
Accession
0001140361-08-003052
Insider Transaction Report
Form 4
Mazzola Donato
Vice President
Transactions
- Award
Stock Option (right to buy)
2008-02-04+12,000→ 12,000 totalExercise: $1.49From: 2009-02-04Exp: 2018-02-03→ Common Stock (12,000 underlying) - Award
Convertible Note
2008-02-04Exercise: $1.84From: 2009-02-04→ Common Stock (163,043 underlying) - Purchase
Common Stock
2008-02-04$1.84/sh+119,565$220,000→ 119,965 total - Award
Series 2 Class B Preferred Stock
2008-02-04+400→ 400 totalExercise: $1.84→ Common Stock (43,478 underlying)
Footnotes (4)
- [F1]The Series 2 Class B Preferred Stock is convertible at the option of the shareholder in the event of a merger or sale of Nyer Medical Group, Inc., or on or after February 4, 2011.
- [F2]The Series 2 Class B Preferred Stock is subject to mandatory conversion on or after February 4, 2011, so long as there are no events of default existing under certain of the Company?s indebtedness and there is an effective resale registration statement filed with respect to the shares of common stock to be issued upon conversion.
- [F3]Donato Mazzola was a minority shareholder of D.A.W., Inc., a subsidiary of Nyer Medical Group, Inc., and acquired the 400 Shares of Series 2 Class B Preferred Stock and the Convertible Note in connection with Nyer Medical Group, Inc.'s acquisition of the minority interest in D.A.W., Inc.
- [F4]The Convertible Note maturity date is February 4, 2011.
Documents
Issuer
NYER MEDICAL GROUP INC
CIK 0000884647
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0000884647
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 7:17 PM ET
- Size
- 13.0 KB